ABL Bio Inc

Company Profile

• Business description

  ABL Bio Inc is a Korean biotech research company. The company is engaged in the research and development of bispecific antibody therapeutics for immuno-oncology and neurodegenerative diseases. It develops therapeutic candidates using its bispecific antibody technology platforms. In the neurodegenerative disorder space, the company develops therapeutics for CNS-related diseases utilizing Grabody-B and Grabody-T for oncology applications. The company's pipeline includes candidates such as ABL111, ABL503, ABL105, ABL104, AB103, etc. The company is also developing bispecific antibody-drug conjugate (ADC) technologies and related therapeutic candidates.

• Contact

  2nd Floor, 16 Daewangpangyo-Ro 712
  Beon-Gil, Bundang-Gu
  Gyeonggi-do
  Seongnam-si13488
  KOR

  T: +82 3180189800

  https://www.ablbio.com

• Sector

  Healthcare

  Stock type

  Defensive

• Industry

  Biotechnology

  Fiscal Year End

  31 December 2026

  Employees

  105